In unctrolled T2DM patients
MET TRIO - 1/2 Tablets
Glimepride 1MG + Voglibose 0.2MG + Metformin 500MGGlimepride 2MG + Voglibose 0.2MG + Metformin 500MG
-
The triple drug combination decreases HbA1c value, FPG and PPG
-
Reduces microvascular complication by 37%
-
98% patients achieved glycemic goal
-
1.4% HbA1c reduction was achieved
-
93% patients compliant with therapy
